TOP NEWS

Kintara Seeking $15.0M In PIPE

San Diego-based biotech Kintara says it is raising $15.0M in a common stock and warrant offering from unmaned "healthcare-focused institutional investors". The company--which is novel cancer therapies for patients who are failing, or are resistant to, current treatment regimens--currently trades on the Nasdaq as KTRA. The company said the exclusive place

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.